PB2109: REALMIND: A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY OF PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA STARTING SECOND/THIRD-LINE THERAPY AND NOT RECEIVING A STEM CELL TRANSPLANT

• C. R. Flowers,
• J. M. Burke,
• M. Vukcevic,
• S. Snodgrass,
• K. Saverno,
• M. A. A. Lumiqued

Affiliations

C. R. Flowers

1 Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston

J. M. Burke

2 US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, Aurora, United States of America

M. Vukcevic

3 MorphoSys AG, Planegg, Germany

S. Snodgrass

4 Incyte Corporation, Wilmington, United States of America

K. Saverno

4 Incyte Corporation, Wilmington, United States of America

M. A. A. Lumiqued

3 MorphoSys AG, Planegg, Germany